Financials

  • Market Capitalization 9.79 B
  • Employee 228
  • Founded 2017
  • CEO N/A
  • Website www.nuvalent.com
  • Headquarter Delaware, United States
  • FIGI BBG00Z1SLMK5
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-17.19
ratio cours/chiffre d'affaires

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
893
ARWR
Arrowhead Pharmaceuticals, Inc. - Common Stock
72.70 USD-1.90%-13.62%-2.48%+85.93%10.24 B USD
906
CYTK
Cytokinetics, Incorporated - Common Stock
81.51 USD-0.89%-5.64%+16.19%+40.29%10.14 B USD
948
IONS
Ionis Pharmaceuticals, Inc. - Common Stock
55.23 USD-2.68%-33.99%-24.85%-23.42%9.13 B USD
959
CORT
Corcept Therapeutics Incorporated - Common Stock
85.98 USD+0.09%-7.51%+3.70%+17.19%9.23 B USD

Nouvelles